Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie

Harald Sourij; Felix Aberer; Marlies Antlanger; Johanna Brix; Daniel Cejka; Martin Clodi; Roland Edlinger; Kathrin Eller; Sabine Horn; Susanne Kaser; Alexandra Kautzky-Willer; Michael Leutner; Rainer Oberbauer; Markus Pirklbauer; Alexander R Rosenkranz; Sabine Schmaldienst; Harald Stingl; David Strobl; Marcus Säemann

doi:10.1007/s00508-025-02671-y

Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie

Translated title of the contribution: Diabetic kidney disease (Update 2026): Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology

Harald Sourij^*
, Felix Aberer
, Marlies Antlanger
, Johanna Brix
, Daniel Cejka
, Martin Clodi
, Roland Edlinger
, Kathrin Eller
, Sabine Horn
, Susanne Kaser
, Alexandra Kautzky-Willer
, Michael Leutner
, Rainer Oberbauer
, Markus Pirklbauer
, Alexander R Rosenkranz
, Sabine Schmaldienst
, Harald Stingl
, David Strobl
, Marcus Säemann

^*Corresponding author for this work

Department of Internal Medicine 2 - Gastroenterology and Hepatology, Endocrinology and Metabolism, Nephrology, Rheumatology

Research output: Contribution to journal › Article › peer-review

Abstract

Epidemiological investigations have shown that approximately 2-3% of all Austrians have diabetes mellitus with renal involvement (diabetic kidney disease, DKD). Therefore, this concerns approximately 250,000 people in Austria. The risk of occurrence and progression of DKD can be attenuated by lifestyle interventions as well as optimization of blood pressure, blood glucose control and specific drug classes. These guidelines represent the joint recommendations of the Austrian Diabetes Association and the Austrian Society of Nephrology for the definition, diagnostics and treatment strategies of DKD.

Translated title of the contribution	Diabetic kidney disease (Update 2026): Guidelines in a collaboration of the Austrian Diabetes Association and the Austrian Society of Nephrology
Original language	German (Austria)
Pages (from-to)	213-227
Number of pages	15
Journal	Wiener klinische Wochenschrift
Volume	138
Issue number	Suppl 4
DOIs	https://doi.org/10.1007/s00508-025-02671-y
Publication status	Published - May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302025 Hepatology
302016 Gastroenterology
302030 Internal medicine

Access to Document

10.1007/s00508-025-02671-y

Cite this

Sourij, H., Aberer, F., Antlanger, M., Brix, J., Cejka, D., Clodi, M., Edlinger, R., Eller, K., Horn, S., Kaser, S., Kautzky-Willer, A., Leutner, M., Oberbauer, R., Pirklbauer, M., Rosenkranz, A. R., Schmaldienst, S., Stingl, H., Strobl, D., & Säemann, M. (2026). Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie. Wiener klinische Wochenschrift, 138(Suppl 4), 213-227. https://doi.org/10.1007/s00508-025-02671-y

@article{b62e29f3acd04e8b8bad55de72c8dae1,

title = "Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der {\"O}sterreichischen Diabetes Gesellschaft und der {\"O}sterreichischen Gesellschaft f{\"u}r Nephrologie",

abstract = "Epidemiological investigations have shown that approximately 2-3\% of all Austrians have diabetes mellitus with renal involvement (diabetic kidney disease, DKD). Therefore, this concerns approximately 250,000 people in Austria. The risk of occurrence and progression of DKD can be attenuated by lifestyle interventions as well as optimization of blood pressure, blood glucose control and specific drug classes. These guidelines represent the joint recommendations of the Austrian Diabetes Association and the Austrian Society of Nephrology for the definition, diagnostics and treatment strategies of DKD.",

keywords = "Humans, Diabetic Nephropathies/therapy, Austria, Diabetes Mellitus, Type 2/therapy, Intersectoral Collaboration, Diabetes Mellitus, Type 1/therapy, Societies, Medical, Risk Factors, Nephrology",

author = "Harald Sourij and Felix Aberer and Marlies Antlanger and Johanna Brix and Daniel Cejka and Martin Clodi and Roland Edlinger and Kathrin Eller and Sabine Horn and Susanne Kaser and Alexandra Kautzky-Willer and Michael Leutner and Rainer Oberbauer and Markus Pirklbauer and Rosenkranz, \{Alexander R\} and Sabine Schmaldienst and Harald Stingl and David Strobl and Marcus S{\"a}emann",

note = "{\textcopyright} 2025. The Author(s).",

year = "2026",

month = may,

doi = "10.1007/s00508-025-02671-y",

language = "Deutsch ({\"O}sterreich)",

volume = "138",

pages = "213--227",

journal = "Wiener klinische Wochenschrift",

issn = "1613-7671",

publisher = "Springer",

number = "Suppl 4",

}

Sourij, H, Aberer, F, Antlanger, M, Brix, J, Cejka, D , Clodi, M, Edlinger, R, Eller, K, Horn, S, Kaser, S, Kautzky-Willer, A, Leutner, M, Oberbauer, R, Pirklbauer, M, Rosenkranz, AR, Schmaldienst, S, Stingl, H, Strobl, D & Säemann, M 2026, 'Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie', Wiener klinische Wochenschrift, vol. 138, no. Suppl 4, pp. 213-227. https://doi.org/10.1007/s00508-025-02671-y

Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie. / Sourij, Harald; Aberer, Felix; Antlanger, Marlies et al.
In: Wiener klinische Wochenschrift, Vol. 138, No. Suppl 4, 05.2026, p. 213-227.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Diabetische Nierenerkrankung (Update 2026)

T2 - Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie

AU - Sourij, Harald

AU - Aberer, Felix

AU - Antlanger, Marlies

AU - Brix, Johanna

AU - Cejka, Daniel

AU - Clodi, Martin

AU - Edlinger, Roland

AU - Eller, Kathrin

AU - Horn, Sabine

AU - Kaser, Susanne

AU - Kautzky-Willer, Alexandra

AU - Leutner, Michael

AU - Oberbauer, Rainer

AU - Pirklbauer, Markus

AU - Rosenkranz, Alexander R

AU - Schmaldienst, Sabine

AU - Stingl, Harald

AU - Strobl, David

AU - Säemann, Marcus

PY - 2026/5

Y1 - 2026/5

N2 - Epidemiological investigations have shown that approximately 2-3% of all Austrians have diabetes mellitus with renal involvement (diabetic kidney disease, DKD). Therefore, this concerns approximately 250,000 people in Austria. The risk of occurrence and progression of DKD can be attenuated by lifestyle interventions as well as optimization of blood pressure, blood glucose control and specific drug classes. These guidelines represent the joint recommendations of the Austrian Diabetes Association and the Austrian Society of Nephrology for the definition, diagnostics and treatment strategies of DKD.

AB - Epidemiological investigations have shown that approximately 2-3% of all Austrians have diabetes mellitus with renal involvement (diabetic kidney disease, DKD). Therefore, this concerns approximately 250,000 people in Austria. The risk of occurrence and progression of DKD can be attenuated by lifestyle interventions as well as optimization of blood pressure, blood glucose control and specific drug classes. These guidelines represent the joint recommendations of the Austrian Diabetes Association and the Austrian Society of Nephrology for the definition, diagnostics and treatment strategies of DKD.

KW - Humans

KW - Diabetic Nephropathies/therapy

KW - Austria

KW - Diabetes Mellitus, Type 2/therapy

KW - Intersectoral Collaboration

KW - Diabetes Mellitus, Type 1/therapy

KW - Societies, Medical

KW - Risk Factors

KW - Nephrology

UR - https://www.scopus.com/pages/publications/105039905475

U2 - 10.1007/s00508-025-02671-y

DO - 10.1007/s00508-025-02671-y

M3 - Artikel

C2 - 42162473

SN - 1613-7671

VL - 138

SP - 213

EP - 227

JO - Wiener klinische Wochenschrift

JF - Wiener klinische Wochenschrift

IS - Suppl 4

ER -

Diabetische Nierenerkrankung (Update 2026): Leitlinie in Zusammenarbeit der Österreichischen Diabetes Gesellschaft und der Österreichischen Gesellschaft für Nephrologie

Abstract

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this